Aurobindo Pharma gets DCGI nod for Molnupiravir generic version

pallavi123- December 29, 2021 0

Aurobindo Pharma has secured consent from the Drugs Controller General of India (DCGI) for manufacturing and distributing its generic version of Covid drug Molnupiravir under ... Read More

Dr. Reddy’s secures EUA for Sputnik V vaccine in India for Covid-19 prevention

pallavi123- April 13, 2021 0

Dr. Reddy’s Laboratories has secured permission from the Drug Controller General of India (DCGI) for importing the Sputnik V vaccine into India under emergency use ... Read More

Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V Covid-19 vaccine

pharmanewsdaily- January 16, 2021 0

Dr. Reddy’s Laboratories has recently received approval from the Drugs Control General of India (DCGI) to proceed with the phase 3 clinical trial of the ... Read More

Dr. Reddy’s reports success in Sputnik V phase 2 trial, paving the way for phase 3 in India

pharmanewsdaily- January 14, 2021 0

Dr. Reddy’s Laboratories has announced a major milestone in the development of Sputnik V, the Russian Covid-19 vaccine, following its successful phase 2 clinical trial ... Read More

India grants emergency approval to Covishield and Covaxin vaccines for Covid-19

pharmanewsdaily- January 3, 2021 0

In a significant development in the battle against Covid-19, the Drugs Controller General of India (DCGI) has granted emergency approval for two vaccines—Covishield, developed by ... Read More

India’s DCGI grants emergency approval to Covishield and Covaxin vaccines

pharmanewsdaily- January 3, 2021 0

In a major step forward in India’s fight against the Covid-19 pandemic, the Drugs Controller General of India (DCGI) has granted emergency use approval to ... Read More

Switzerland approves Pfizer-BioNTech Covid-19 vaccine for emergency use, marking global first

pharmanewsdaily- December 20, 2020 0

Switzerland has become the first country to grant full approval for the Pfizer-BioNTech BNT162b2 Covid-19 vaccine, making a significant move in the global race against ... Read More

Lilly to launch real-world Covid-19 study of bamlanivimab in New Mexico

pharmanewsdaily- December 19, 2020 0

Eli Lilly and Company (Lilly), a global leader in the pharmaceutical industry, has announced plans to conduct a new pragmatic study of its experimental Covid-19 ... Read More

Pfizer and BioNTech’s COVID-19 vaccine secures FDA emergency use authorization

pharmanewsdaily- December 11, 2020 0

In a groundbreaking move, Pfizer and BioNTech have received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for their COVID-19 vaccine, ... Read More

Lilly signs $375m deal to supply Covid-19 candidate bamlanivimab to US govt

pharmanewsdaily- October 29, 2020 0

Eli Lilly and Company (Lilly) has signed a $375 million deal with the US government for the supply of 300,000 vials of bamlanivimab (LY-CoV555) 700mg, ... Read More